BY PAUL ECCLES, ANDJELA MILIVOJEVIC AND RACHEL SCHRAER ADDITIONAL REPORTING BY SHAFA’ATU SULEIMAN AND LAURA MARGOTTINI He ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback